World APS Day: Shining a Light on a Silent but Life-Threatening Autoimmune Disorder
The APS Foundation of America has shared an important update on their official X page in recognition of World APS Day. The post emphasizes the urgent need to raise awareness about Antiphospholipid Syndrome (APS)—an incurable, life-threatening autoimmune disorder that increases the risk of dangerous blood clots.
“Today is World APS Day, the global awareness campaign to raise awareness of Antiphospholipid Syndrome and its impact on our lives.
APS is an incurable, life-threatening autoimmune condition that causes the blood to clot.”
What is APS?
APS occurs when the immune system mistakenly produces antibodies that target phospholipids—critical components of cell membranes—leading to an increased risk of:
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Stroke
- Recurrent miscarriage
- Catastrophic multiorgan thrombosis in severe cases
Despite its profound clinical impact, APS remains underdiagnosed and misunderstood.
Hemostasis Today proudly joins the global movement to raise awareness, promote early diagnosis, and support ongoing research into this devastating condition. As we commemorate World APS Day, we stand with patients, families, and advocates in calling for increased education, improved testing, and more targeted therapies.
Let today be a reminder: Clots can kill, but knowledge can save lives.
Follow us on Hemostasis Today for expert insights, clinical updates, and patient stories throughout APS Awareness Month.
-
Jun 12, 2025, 10:34Apply Now: HTRS Funding Opportunities for Aspiring Hemostasis Researchers
-
Jun 12, 2025, 10:33Review of Factor IX Replacement Therapy in Hemophilia B with CSL Behring on June 22
-
Jun 12, 2025, 10:30Dr. Laura Girardi Awarded 2025 Thrombosis Canada – CanVECTOR Research Fellowship
-
Jun 12, 2025, 10:21Elevate Your Career: American Society of Hematology Clinical Research Training Institute in the Mediterranean, Middle East, and North Africa
-
Jun 12, 2025, 07:45Richard Kelly - Is it possible to discontinue anticoagulation in patients with PNH?
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Jun 6, 2025, 15:52Long-term Efficacy and Safety of Mitapivat in Non-Transfusion-Dependent α- or β-thalassaemia - British Journal of Haematology
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation